Finance

Lists
ADIL:NASDAQ
Adial Pharmaceuticals Inc
$4.90
-18.27%
(-1.09) 1D
Sep 11, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ADIL...
Open
$6.06
High
$6.11
Low
$4.80
Mkt. cap
12.86M
Avg. vol.
74.69K
Volume
108.48K
52-wk high
$10.75
52-wk low
$1.31
EPS
-$16.57
Beta
1.38
Shares outstanding
2.63M
No. of employees
5
Open
$6.06
High
$6.11
Low
$4.80
Mkt. cap
12.86M
Avg. vol.
74.69K
Volume
108.48K
52-wk high
$10.75
52-wk low
$1.31
EPS
-$16.57
Beta
1.38
Shares outstanding
2.63M
No. of employees
5
News stories
From web sources and news partners
About Adial Pharmaceuticals Inc
CEO-
Employees5
Founded2010
HeadquartersCharlottesville, Virginia, United States
SectorPharmaceutical industry
Websiteadial.com
Analyst ratings
Based on 2 analysts giving stock ratings to ADIL in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for ADIL in the last 3 months.
Highest
Current $4.90
$11.00 (+124.49%)
Average
$8.50 (+73.47%)
Lowest
$6.00 (+22.45%)
Analyst
Recommendation
Action
Price target
Projected
Date
James Molloy
Alliance Global Partners
Buy
Initiated
$11.00
+124.5%
08/03/2026
Elemer Piros
Lucid Capital
Buy
Initiated
$6.00
+22.4%
06/15/2026
Jason McCarthy
Maxim Group
Buy
Maintained
$8.00
+63.3%
05/12/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
521.07K
619.40K
432.53K
440.00K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.24M
1.27M
1.57M
5.40M
Operating expense
1.76M
1.89M
2.00M
5.84M
Total operating expenses
1.76M
1.89M
2.00M
5.84M
Operating income
-1.76M
-1.89M
-2.00M
-5.84M
Other non operating income
-513.00
-8.00
-
8.28M
EBT including unusual items
-1.79M
-2.00M
-2.02M
-51.99M
EBT excluding unusual items
-1.79M
-2.00M
-2.02M
250.00K
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-1.79M
-2.00M
-2.02M
-51.99M
Net profit margin
-
-
-
-
Earnings per share
-2.00
-11.48
-1.48
-1.29
Interest and investment income
47.86K
42.61K
47.06K
58.00K
Interest expense
-
-
-
-2.07M
Net interest expenses
47.86K
42.61K
47.06K
-2.01M
Depreciation and amortization charges
-
-
-
-
EBITDA
-1.76M
-1.89M
-2.00M
-5.84M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps